Form D · Biotechnology

Optherion Inc

New Haven, CT · CIK 0001396827

Offering snapshot reported Sep 16, 2009 · SEC filing

Reported sold
$5M
Offering amount: $9.45M
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 2, 2009
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 16, 2009Initial$5,000,000No comparison10SEC filing
Aug 6, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Apr 16, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-102365
Total Offering Amount represents the aggregate amount of convertible unsecured promissory notes and warrants to be issued as part of offering. The notes and warrants are convertible into capital stock of the Company pursuant to their respective terms.

Source: Form D, filed Sep 16, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
George Elston Executive
Colin Foster Director, Executive, Promoter
Brian K. Halak Director
Eileen More Director
Sherrill P. Neff Director
& Company Inc. Scheer Promoter
David I. Scheer Director, Promoter

Issuer details

Industry: Biotechnology (See others in industry)

Address:
555 Long Wharf Drive, 11 Th Floor
New Haven, CT, 06511